List of Study Group 2013-2014
***2014***
1.
Moritake H, Kamimura S, Nunoi H, Nakayama H, Suminoe A, Inada H, Inagaki J, Yanai F, Okamoto Y, Shinkoda Y, Shimomura M,
Itonaga N, Hotta N, Hidaka Y, Ohara O, Yanagimachi M, Nakajima N, Okamura J, Kawano Y. Clinical characteristics and genetic
analysis of childhood acute lymphoblastic leukemia with hemophagocytic lymphohistiocytosis: a Japanese retrospective study by
the Kyushu–Yamaguchi Children’s Cancer Study Group. Int. J. Hematol. 100:70-78, 2014
2.
Kato M, Manabe A, Koh K, Inukai T, Kiyokawa N, Fukushima T, Goto H, Hasegawa D, Ogawa C, Koike K, Ota S, Noguchi Y,
Kikuchi A, Tsuchida M, Ohara A. Treatment outcomes of adolescent acute lymphoblastic leukemia treated on Tokyo Children’s
Cancer Study Group (TCCSG) clinical trials. Int. J. Hematol. 100:180-187, 2014
3.
Hirayama Y, Ishitani K, Ota S, Kurosawa M, Kondo T, Takimoto R, Mori A, Sakai H, Torimoto Y, Yamamoto S, Sato K, Iwasaki H,
Kohda K, Ishida T, Kakinoki Y, Fukuhara T, Kato J. Long-term survey of survival time, histological transformation, and secondary
malignancies in Japanese patients with advanced-stage follicular lymphoma in the rituximab era: Hokkaido Hematology Study
Group. Int. J. Hematol. 100:281-289, 2014
***2013***
1.
Morimoto A, Shimazaki C, Takahashi S, Yoshikawa K, Nishimura R, Wakita H, Kobayashi Y, Kanegane H, Tojo A, Imamura T.
Therapeutic outcome of multifocal Langerhans cell histiocytosis in adults treated with the Special C regimen formulated by the
Japan LCH Study Group. Int. J. Hematol. 97:103-108, 2013
2.
Torimoto Y, Sato K, Ikuta K, Hayashi T, Hirayama Y, Inamura J, Kobayashi H, Kobayashi R, Koda K, Kurosawa M, Mori A, Ota S,
Sakai H, Shigematsu A, Shindo M, Shinzaki H, Takahashi F, Takimoto R, Tanaka J, Yamamoto S, Kohgo Y, Fukuhara T. A
retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology
Study Group. Int. J. Hematol. 98:171-178, 2013
3.
Sano H, Shimada A, Tabuchi K, Taki T, Murata C, Park M, Ohki K, Sotomatsu M, Adachi S, Tawa A, Kobayashi R, Horibe K,
Tsuchida M, Hanada R, Tsukimoto I, Hayashi Y. WT1 mutation in pediatric patients with acute myeloid leukemia: a report from the
Japanese Childhood AML Cooperative Study Group. Int. J. Hematol. 98:437-445, 2013
4.
Tomizawa D, Tawa A, Watanabe T, Saito AM, Kudo K, Taga T, Iwamoto S, Shimada A, Terui K, Moritake H, Kinoshita A, Takahashi
H, Nakayama H, Kiyokawa N, Isoyama K, Mizutani S, Hara J, Horibe K, Nakahata T, Adachi S. Appropriate dose reduction in
induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric
Leukemia/Lymphoma Study Group. Int. J. Hematol. 98:578-588, 2013